Alzheimer disease and cerebrovascular pathology: an update
The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
Recent epidemiological and clinico-pathologic data suggest overlaps between Alzheimer disease (AD) and cerebrovascular lesions that may magnify the effect of mild AD pathology and promote progression of cognitive decline or even may precede neuronal damage and dementia. Vascular pathology in the aging brain and in AD includes: 1. cerebral amyloid angiopathy (CAA) with an incidence of 82-98% often associated with ApoE epsilon 2 and causing a) cerebral mass hemorrhages (around 70%, mainly in the frontal and parietal lobes), b) multiple or recurrent microhemorrhages (15%), and c) ischemic (micro-)infarcts or lacunes (around 20%). The frequency of these lesions increases with the severity of CAA and shows no correlation with that of senile amyloid plaques. CAA, significantly more frequent in patients with cerebral hemorrhages or infarcts than in aged controls, is an important risk factor for cerebrovascular lesions in AD. 2. Microvascular changes with decreased density and structural abnormalities causing regional metabolic and blood-brain barrier dysfunctions with ensuing neuronal damage. In large autopsy series of demented aged subjects, around 80% show Alzheimer type pathology, 20-40% with additional, often minor vascular lesions, 7-10% "pure" vascular dementia, and 3-5% "mixed" dementia (combination of AD and vascular encephalopathy). AD cases with additional minor cerebrovascular lesions have significantly more frequent histories of hypertension or infarcts than "pure" AD patients. Vascular lesions in AD include cortical microinfarcts, subcortical lacunes, white matter lesions / leukoencephalopathy, small hemorrhages and corticosubcortical infarcts, while in mixed type dementia multiple larger or hemispheral infarcts are more frequent. Small infarcts in AD patients have no essential impact on global cognitive decline which mainly depends on the severity of Alzheimer pathology, but in early stage of AD they may influence and promote the development of dementia. Recent studies showed lower density of plaques and tangles in brains with cerebrovascular lesions, and similar severity of dementia was related to fewer AD lesions in brains with than in those without small vascular lesions. Further studies will help to elucidate the risk factors and impact of cerebrovascular lesions on the development and progression of dementia in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CAA appears in ≈10% to 30% of unselected brain autopsies and 80% to 100% when in the presence of accompanying Alzheimer disease.136”
In the citing paper
“which virtually all individuals with AD and about a third of aged cognitively normal individuals have) [68, 179]”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [68]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 2×
“of currently used neuropathological diagnostic criteria for AD (Mirra et al., 1991; Braak and Braak, 1991; Hyman, 1998).”
BackgroundMethodMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084 · cited 2×
“…to many authors, MD should be diagnosed only if there are sufficient vascular and degenerative lesions to make each diagnosis independently (Tomlinson et al., 1970; Boller et al., 1989; Erkinjuntti, 1988; Jellinger et al., 1990; Mirra et al., 1991), while others suggest the diagnosis of AD…”
Background15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726 · cited 1×
“An association between hypertension and AD has been reported in several prospective studies (Skoog et al., 1993, 1996; Hofman et al., 1997; Skoog, 2000; Launer et al., 2000; Meyer et al., 2000; Schmidt et al., 2000; Kivipelto et al., 2001).”
BackgroundKivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618 · cited 2×
“An association between hypertension and AD has been reported in several prospective studies (Skoog et al., 1993, 1996; Hofman et al., 1997; Skoog, 2000; Launer et al., 2000; Meyer et al., 2000; Schmidt et al., 2000; Kivipelto et al., 2001).”
Background(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338 · cited 2×
“that came to autopsy, but most patients had mixed disease without clear thresholds of pathological features that predicted dementia (Esiri et al., 2001).”
BackgroundChui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201 · cited 2×
“, 1991), while in the ADDTC criteria (Chui et al., 1992), a second cerebrovascular disorder in addition to AD must be shown to”
BackgroundCerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102 · cited 6×
“…vessels (Claudio, 1996; Farkas et al., 2000) with increase of collagen IV (Kalaria and Pax, 1995) and breakdown of the BBB are considered important factors for disturbances of cerebral metabolism, reduced cerebral blood flow and neural metabolic changes (Shi et al., 2000; Farkas and Luiten, 2001).”
BackgroundInfluentialHofman, A., Ott, A., Breteler, M. M., Bots, M. L., Slooter, A. J., van Harskamp, F., van Duijn, C. N., Van Broeckhoven, C., & Grobbee, D. E. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09328-2 · Cited by 1,062 · cited 4×
“Hypertension and hypercholesterinemia, independent of the ApoE genotype have been shown to be risk factors for AD (Hofman et al., 1997; Skoog et al., 1999).”
BackgroundInfluentialClinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria
Knudsen, K. A., Rosand, J., Karluk, D., & Greenberg, S. M. (2001) · Neurology · doi:10.1212/wnl.56.4.537 · Cited by 1,015
Cited by
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Peters, R. (2006) · Postgraduate Medical Journal · doi:10.1136/pgmj.2005.036665 · Cited by 894
Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease
Bell, R. D., & Zlokovic, B. V. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0522-3 · Cited by 860
Alzheimer's disease: experimental models and reality
Drummond, E., & Wisniewski, T. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1662-x · Cited by 810
“Hence, the preclinical testing of therapeutic approaches in models with extensive CAA (which virtually all individuals with AD and about a third of aged cognitively normal individuals have) [68, 179] and showing that it does not induce microhemorrhages is of importance.”
BackgroundThe blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767
“Furthermore, the expression of occludin, claudin-5, and ZO-1 was strongly suppressed in the A β -laden capillaries of patients with capillary CAA, suggesting that the modulation of TJ protein expression may increase vascular permeability in the AD brain (Carrano et al., 2011; Carrano et al., 2012).”
InfluentialCharacterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., Prada, C., Greenberg, S. M., Bacskai, B. J., & Frosch, M. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.017 · Cited by 744
“CAA is present in up to 80% of cases of AD diagnosed at autopsy (Jellinger, 2002; Weller et al., 2000, 2004), suggesting that cerebrovascular disease may be a factor in the failure of elimination of Aβ from the brain in AD, linking aging in cerebral arteries with the pathogenesis of AD (Nicoll et…”
BackgroundThe overlap between vascular disease and Alzheimer’s disease - lessons from pathology
Attems, J., & Jellinger, K. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0206-2 · Cited by 739
“, hypertensive vasculopathy), or microvascular degeneration (tortuosity, fibro- and lipohyalinosis,); – Blood–brain barrier (BBB) dysfunction causing white matter lesions (WMLs), microinfarctions, lacunes or lacunar infarcts, and microbleeds [17,87].”
BackgroundInfluentialSelf-citationPost-stroke cognitive impairment: epidemiology, mechanisms and management.
(2014) · PubMed Central · doi:10.3978/j.issn.2305-5839.2014.08.05 · Cited by 680
“The CAA, which is a common cause of the stroke especially the hemorrhage stroke, is found in about 90% cases of AD (60,72).”
BackgroundGarcia‐Alloza, M., Borrelli, L. A., Rozkalne, A., Hyman, B. T., & Bacskai, B. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04613.x · Cited by 661
Cerebral amyloid angiopathy in the elderly
Viswanathan, A., & Greenberg, S. M. (2011) · Annals of Neurology · doi:10.1002/ana.22516 · Cited by 643
“The signal characteristics, size, and location of these DWI-positive lesions suggest they may represent the neuroimaging correlates of the neuropathologic infarctions described in association with CAA.48–52 Given the transient appearance of DWI-positive signal after stroke, the finding of these DWI-positive lesions in…”
BackgroundInfluentialCharidimou, A., Gang, Q., & Werring, D. J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301308 · Cited by 611
“In Alzheimer ’s disease (AD), CAA is almost invariable being found at autopsy in more than 90% of cases.(17) 25 However, most of these patients have mild CAA; severe CAA is found in about 25% of AD brains.”
BackgroundDichgans, M., & Leys, D. (2017) · Circulation Research · doi:10.1161/circresaha.116.308426 · Cited by 581
“In patients with concomitant AD, the prevalence of CAA at autopsy is >80%.(209,210) In the population-based Honolulu-Asia Aging Study, 44.”
BackgroundBlood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease
Erickson, M. A., & Banks, W. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.135 · Cited by 572
Emerging concepts in sporadic cerebral amyloid angiopathy
Charidimou, A., Boulouis, G., Gurol, M. E., Ayata, C., Bacskai, B. J., Frosch, M. P., Viswanathan, A., & Greenberg, S. M. (2017) · Brain · doi:10.1093/brain/awx047 · Cited by 555
“In Alzheimer’s disease brains, CAA is identified in an estimated 85–95% of the cases when sought diligently (Kalaria and Ballard, 1999; Jellinger, 2002).”
BackgroundCerebral Hemorrhage After Passive Anti-Aβ Immunotherapy
Pfeifer, M., Boncristiano, S., Bondolfi, L., Stalder, A., Deller, T., Staufenbiel, M., Mathews, P. M., & Jucker, M. (2002) · Science · doi:10.1126/science.1078259 · Cited by 511
Retinal Abnormalities in Early Alzheimer’s Disease
Berisha, F., Feke, G. T., Trempe, C. L., McMeel, J. W., & Schepens, C. L. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-1029 · Cited by 504
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy
Johnson, K. A., Gregas, M., Becker, J. A., Kinnecom, C., Salat, D. H., Moran, E. K., Smith, E. E., Rosand, J., Rentz, D. M., Klunk, W. E., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21164 · Cited by 495
“We therefore undertook a comparison of the location and extent of amyloid deposition in CAA, AD, and healthy older subjects, testing the hypothesis that PiB retention similar to that seen in AD is evident in CAA.”
BackgroundInfluentialCerebral White Matter: Neuroanatomy, Clinical Neurology, and Neurobehavioral Correlates
Schmahmann, J. D., Smith, E. E., Eichler, F. S., & Filley, C. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1444.017 · Cited by 486
Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer’s disease
Lester-Coll, N., Rivera, E. J., Soscia, S. J., Doiron, K., Wands, J. R., & de la Monte, S. M. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9102 · Cited by 467
“…ischemia-reperfusion in human brains are clearly distinguishable from the neurodegenerative changes associated with cognitive impairment in AD [94,95]; 2) hypoxic and ischemic injuries are either global or they follow vascular territories with relatively little selectiveness for cell type,…”
The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease
Minter, M. R., Taylor, J. M., & Crack, P. J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13411 · Cited by 451
Cerebral Amyloid Angiopathy: A Systematic Review
Biffi, A., & Greenberg, S. M. (2011) · Journal of Clinical Neurology · doi:10.3988/jcn.2011.7.1.1 · Cited by 443
Daulatzai, M. A. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23777 · Cited by 429
Grammas, P. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-26 · Cited by 432
“On the contrary, it has been suggested that the angiogenic process is delayed and/or impaired in aged tissues, with several studies showing decreased microvascular density in the AD brain [111-113].”
BackgroundSantos, C. Y., Snyder, P. J., Wu, W., Zhang, M., Echeverria, A., & Alber, J. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.01.005 · Cited by 431
Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics
Hampel, H., Elhage, A., Cho, M., Apostolova, L. G., Nicoll, J. A. R., & Atri, A. (2023) · Brain · doi:10.1093/brain/awad188 · Cited by 412
Schmidt, R., Ropele, S., Enzinger, C., Petrovic, K., Smith, S., Schmidt, H., Matthews, P. M., & Fazekas, F. (2005) · Annals of Neurology · doi:10.1002/ana.20630 · Cited by 408
“Yet, others believe that in Alzheimer patients white matter lesions develop as the consequence of amyloid angiopathy.(29,30) In this context, note that a small subgroup of our study participants had no brain atrophy but extensive white matter changes at baseline.”
BackgroundWilcock, D. M., Rojiani, A. M., Rosenthal, A., Subbarao, S., Freeman, M. J., Gordon, M. N., & Morgan, D. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-24 · Cited by 421
Thal, D. R., Ghebremedhin, E., Orantes, M., & Wiestler, O. D. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.12.1287 · Cited by 384
“Cases with an overlapping pattern of vascular and AD lesions are often categorized as mixed dementia or as AD with cerebrovascular disease (5, 49).”
BackgroundResultCerebral amyloid angiopathy and its relationship to Alzheimer’s disease
Thal, D. R., Griffin, W. S. T., de Vos, R. A. I., & Ghebremedhin, E. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0366-2 · Cited by 372
“More than 80% of the AD patients exhibit CAA [6, 36, 37, 101].”
BackgroundReview: sporadic cerebral amyloid angiopathy
Attems, J., Jellinger, K., Thal, D. R., & Van Nostrand, W. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01137.x · Cited by 371
Self-citationVascular pathology in the aged human brain
Grinberg, L. T., & Thal, D. R. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0652-7 · Cited by 345
“In the sporadic form of CAA, vascular Ab deposition is strongly associated with AD-related pathology and around 80– 100% of all AD patients have CAA [3, 4, 51, 55, 108, 126, 129, 132, 141].”
BackgroundIntracerebral hemorrhage: an update on diagnosis and treatment
Hostettler, I. C., Seiffge, D. J., & Werring, D. J. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1623671 · Cited by 341
Phenotype associated with APP duplication in five families
Cabrejo, L., Guyant-Marechal, L., Laquerriere, A., Vercelletto, M., De La Fourniere, F., Thomas-Anterion, C., Verny, C., Letournel, F., Pasquier, F., Vital, A., et al. (2006) · Brain · doi:10.1093/brain/awl237 · Cited by 343
“In Alzheimer’s disease and Down’s syndrome, CAA is caused by deposition of amyloid b peptides (Ab) and associated with pathological hallmarks of Alzheimer’s disease (Ellis et al., 1996; Jellinger, 2002; Pfeifer et al., 2002).”
BackgroundVascular Cognitive Impairment (VCI)
Rundek, T., Tolea, M., Ariko, T., Fagerli, E. A., & Camargo, C. J. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01170-y · Cited by 305
Boekhoorn, K., Joels, M., & Lucassen, P. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.017 · Cited by 325
Racke, M. M., Boone, L. I., Hepburn, D. L., Parsadainian, M., Bryan, M. T., Ness, D. K., Piroozi, K. S., Jordan, W. H., Brown, D. D., Hoffman, W. P., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4337-04.2005 · Cited by 320
“Although the degree of CAA is quite variable, its prevalence in confirmed AD patients is quite high and is observed in 80 –90% of patients at autopsy (Jellinger, 2002; Rensink et al., 2003).”
BackgroundPrevalence and severity of microbleeds in a memory clinic setting
Cordonnier, C., van der Flier, W. M., Sluimer, J. D., Leys, D., Barkhof, F., & Scheltens, P. (2006) · Neurology · doi:10.1212/01.wnl.0000210535.20297.ae · Cited by 305
Amyloid Angiopathy–Related Vascular Cognitive Impairment
Greenberg, S. M., Gurol, M. E., Rosand, J., & Smith, E. E. (2004) · Stroke · doi:10.1161/01.str.0000143224.36527.44 · Cited by 298
Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s disease
Frost, S., Kanagasingam, Y., Sohrabi, H., Vignarajan, J., Bourgeat, P., Salvado, O., Villemagne, V, Rowe, C. C., Lance Macaulay, S., Szoeke, C., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.150 · Cited by 297
Baker, L. D., Frank, L. L., Foster-Schubert, K., Green, P. S., Wilkinson, C. W., McTiernan, A., Cholerton, B. A., Plymate, S. R., Fishel, M. A., Watson, G. S., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100768 · Cited by 293
“Thus, aerobic exercise may have its greatest remediatingeffect on frontal brain regions that are most vulnerable to aging, and for glucose intolerant adults with an increased risk of cognitive decline and AD, to deleterious consequences of diabetes-and AD-related vascular dysfunction [48,66,67].”
Rockenstein, E., Torrance, M., Adame, A., Mante, M., Bar-on, P., Rose, J. B., Crews, L., & Masliah, E. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4321-06.2007 · Cited by 288
“…throughout the association cortex and limbic system (Hof and Morrison, 1994), deposition of amyloid- protein (A ) in the neuropil (Jellinger and Bancher, 1998) and around blood vessels (Jellinger, 2002), and formation of intraneuronal neurofibrillary tangles (NFTs) (Trojanowski and Lee, 2000).”
BackgroundNeuropathological evaluation of mixed dementia
Jellinger, K. A., & Attems, J. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.045 · Cited by 272
Self-citationPettersen, J. A., Sathiyamoorthy, G., Gao, F.-Q., Szilagyi, G., Nadkarni, N. K., St George-Hyslop, P., Rogaeva, E., & Black, S. E. (2008) · Archives of Neurology · doi:10.1001/archneur.65.6.790 · Cited by 264
SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells
Bell, R. D., Deane, R., Chow, N., Long, X., Sagare, A., Singh, I., Streb, J. W., Guo, H., Rubio, A., Van Nostrand, W., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1819 · Cited by 261
“, the prevalence of which is greater than 80% in AD individuals and 10–40% in the elderly population without A”
BackgroundLewy body-related ?-synucleinopathy in the aged human brain
Jellinger, K. A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0138-7 · Cited by 256
“The pathogenic impact of both cortical LB and AD pathology for the develoment of dementia in PD and its distinction from DLB is not clear and a matter of considerable discussion (Burn, 2004; Jellinger, 2002; Jellinger and Mizuno, 2003; Mosimann and McKeith, 2003).”
BackgroundSelf-citationSporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms
Attems, J. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1074-9 · Cited by 242
“6% [51] in AD (Table 1), and therefore it is generally assumed that CAA is strongly associated with AD.”
BackgroundBeach, T. G., Wilson, J. R., Sue, L. I., Newell, A., Poston, M., Cisneros, R., Pandya, Y., Esh, C., Connor, D. J., Sabbagh, M., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0136-y · Cited by 233
“Postmortem studies have found that both the severity of intracranial AVD [32] and the frequency of brain lesions associated with AVD [9, 29, 30] are increased in AD subjects.”
BackgroundCholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease
Martins, I. J., Berger, T., Sharman, M. J., Verdile, G., Fuller, S. J., & Martins, R. N. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06408.x · Cited by 232
Emerging Concepts in Alzheimer's Disease
Vinters, H. V. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163927 · Cited by 235
Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging
Solfrizzi, V., Scafato, E., Frisardi, V., Seripa, D., Logroscino, G., Maggi, S., Imbimbo, B. P., Galluzzo, L., Baldereschi, M., Gandin, C., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.09.223 · Cited by 223
“In fact, vascular pathology of the aging brain and AD includes cerebral amyloid angiopathy, which leads to lobar mass hemorrhages, small or recurrent bleeds and ischemic infarcts, microvascular degeneration, disorder of the blood– brain barrier, white matter lesions, microinfarctions, lacunes, and cerebral hemorrhages…”
BackgroundThe enigma of vascular cognitive disorder and vascular dementia
Jellinger, K. A. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0185-2 · Cited by 166
“CAA-related intracerebral hemorrhages are seen in 5–20% of all spontaneous (nontraumatic) bleeds in elderly subjects [243, 512].”
BackgroundSelf-citationThe Relationship between Obstructive Sleep Apnea and Alzheimer’s Disease
Andrade, A. G., Bubu, O. M., Varga, A. W., & Osorio, R. S. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179936 · Cited by 216
“Second, stroke can not only potentiate the clinical expression of AD [151], but several studies have shown that cerebral microinfarcts and intracranial atherosclerosis can increase the risk of AD [152, 153].”
Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease
Farfara, D., Lifshitz, V., & Frenkel, D. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00314.x · Cited by 216
“In AD, the deposition of amyloid around cerebral blood vessels can lead to CAA which occurs in 80% of AD cases [108].”
BackgroundThe nature and effects of cortical microvascular pathology in aging and Alzheimer's disease
Bailey, T. L., Rivara, C. B., Rocher, A. B., & Hof, P. R. (2004) · Neurological Research · doi:10.1179/016164104225016272 · Cited by 213
Xiong, H., Callaghan, D., Jones, A., Bai, J., Rasquinha, I., Smith, C., Pei, K., Walker, D., Lue, L.-F., Stanimirovic, D., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5103-08.2009 · Cited by 202
“, hypertension, diabetes, hypercholesterolemia) (Jellinger, 2002), we cannot completely exclude the possibility that the observed upregulation of ABCG2 in brain vessels in AD/CAA might be associated with vascular pathology not directly related to AD.”
BackgroundInfluentialMiao, J., Xu, F., Davis, J., Otte-Höller, I., Verbeek, M. M., & Van Nostrand, W. E. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62993-8 · Cited by 199
The Cerebral β-Amyloid Angiopathies: Hereditary and Sporadic
Zhang-Nunes, S. X., Maat-Schieman, M. L. C., Duinen, S. G., Roos, R. A. C., Frosch, M. P., & Greenberg, S. M. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.tb00559.x · Cited by 193
“More comprehensive reviews of sporadic CAA are available from our group and others (28, 29, 47, 49, 98).”
BackgroundFan, R., Xu, F., Previti, M. L., Davis, J., Grande, A. M., Robinson, J. K., & Van Nostrand, W. E. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4371-06.2007 · Cited by 196
“In addition to parenchymal plaques, fibrillar A deposition in the cerebral vasculature, a condition known as cerebral amyloid angiopathy (CAA), is commonly found in AD (Jellinger, 2002; Rensink et al., 2003; Zhang-Nunes et al., 2006).”
BackgroundCullen, K. M., Kócsi, Z., & Stone, J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.016 · Cited by 197
Serum levels of S100B and NSE proteins in Alzheimer's disease patients
Chaves, M. L., Camozzato, A. L., Ferreira, E. D., Piazenski, I., Kochhann, R., Dall'Igna, O., Mazzini, G. S., Souza, D. O., & Portela, L. V. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-6 · Cited by 188
“Moreover, recent epidemiological and clinico-pathologic data suggest overlaps between AD and cerebrovascular lesions that may magnify the effect of mild AD pathology and promote progression of cognitive decline or even may precede neuronal damage and dementia [34].”
BackgroundAttems, J., Jellinger, K. A., & Lintner, F. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1064-y · Cited by 188
“These data are in accordance with CAA prevalence rates of 80% to almost 100% [18, 40, 45, 48] in AD, but are somewhat higher than the 10–40% prevalence rates reported in the general elderly population [12, 18, 30, 55, 61, 65].”
BackgroundResultInfluentialSelf-citationLipid metabolism in cognitive decline and dementia
Panza, F., D'Introno, A., Colacicco, A. M., Capurso, C., Pichichero, G., Capurso, S. A., Capurso, A., & Solfrizzi, V. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.11.007 · Cited by 189
“Vascular pathology of the aging brain and AD includes cerebral amyloid angiopathy (CAA), causing lobar mass hemorrhages, small or recurrent bleeds and ischemic infarcts, microvascular degeneration, disorder of the blood–brain barrier (BBB), white matter lesions, microinfarctions, lacunes, and cerebral hemorrhages (Jel…”
BackgroundMorphometry of the human substantia nigra in ageing and Parkinson’s disease
Rudow, G., O’Brien, R., Savonenko, A. V., Resnick, S. M., Zonderman, A. B., Pletnikova, O., Marsh, L., Dawson, T. M., Crain, B. J., West, M. J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0352-8 · Cited by 171
“hippocampus, amygdala, neocortex, and olfactory bulb [3, 5, 12, 24], the degeneration of the SN pars compacta and its dopaminergic projection to the striatum is the most salient morphological feature of PD and plays a preeminent role in the motor manifestations that characterize the disease.”
Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review
Keage, H. A., Carare, R. O., Friedland, R. P., Ince, P. G., Love, S., Nicoll, J. A., Wharton, S. B., Weller, R. O., & Brayne, C. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-3 · Cited by 181
“It was reported that capillary CAA is more closely associated with impaired cognition than is CAA of larger blood vessels [30,79].”
Vascular contributions to Alzheimer's disease
Eisenmenger, L. B., Peret, A., Famakin, B. M., Spahic, A., Roberts, G. S., Bockholt, J. H., Johnson, K. M., & Paulsen, J. S. (2023) · Translational Research · doi:10.1016/j.trsl.2022.12.003 · Cited by 169
Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology?a pilot study
Attems, J., & Jellinger, K. A. (2004) · Acta Neuropathologica · doi:10.1007/s00401-003-0796-9 · Cited by 181
“Its incidence and severity increase with age [6, 9, 12 , 18, 29, 30, 31, 37, 45], and it is frequent and severe in a variety of familial disorders associated with mutations of the amyloid precursor protein [10, 17, 22, 29, 30, 31].”
BackgroundResultInfluentialSelf-citationGharbiya, M., Trebbastoni, A., Parisi, F., Manganiello, S., Cruciani, F., D'Antonio, F., De Vico, U., Imbriano, L., Campanelli, A., & De Lena, C. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-132039 · Cited by 174
“A cerebral blood vessels have been shown in AD, resulting in arterial hypercontractility and increased vascular resistance [38, 39].”
Brenowitz, W. D., Nelson, P. T., Besser, L. M., Heller, K. B., & Kukull, W. A. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.06.028 · Cited by 174
“The presence of CAA in patients with AD may have a greater clinical impact than AD alone (Jellinger, 2002; Thal et al., 2003).”
Rossi, B., Angiari, S., Zenaro, E., Budui, S. L., & Constantin, G. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0710432 · Cited by 172
“A is also deposited in the vascular wall of intracerebral and leptomeningeal vessels causing CAA, which is present in 80% of AD brains [222–224].”
BackgroundHeart failure and Alzheimer′s disease
Cermakova, P., Eriksdotter, M., Lund, L. H., Winblad, B., Religa, P., & Religa, D. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12287 · Cited by 163
Miners, J. S., Ashby, E., Van Helmond, Z., Chalmers, K. A., Palmer, L. E., Love, S., & Kehoe, P. G. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00885.x · Cited by 166
Topography of dilated perivascular spaces in subjects from a memory clinic cohort
Martinez-Ramirez, S., Pontes-Neto, O. M., Dumas, A. P., Auriel, E., Halpin, A., Quimby, M., Gurol, M. E., Greenberg, S. M., & Viswanathan, A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828f1876 · Cited by 163
“In patients with AD, lobar MB may be even more suggestive of the presence of CAA, as more than 80% of patients with AD have some degree of CAA at pathologic examination.(25) As our cohort was largely comprised of patients with MCI and established ADrelated dementia, the pattern of lobar MB seen in these patients may b…”
BackgroundMetabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms
Panza, F., Frisardi, V., Capurso, C., Imbimbo, B. P., Vendemiale, G., Santamato, A., D'Onofrio, G., Seripa, D., Sancarlo, D., Pilotto, A., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091669 · Cited by 163
“Vascular pathology of the aging brain and AD includes cerebral amyloid angiopathy (CAA), causing lobar mass hemorrhages, small or recurrent bleeds and ischemic infarcts, microvascular degeneration, disorder of the blood-brain barrier (BBB), WMLs, microinfarctions, lacunes, and cerebral hemorrhages [183].”
Tomimoto, H. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.07.1820 · Cited by 161
Vogelgesang, S., Warzok, R., Cascorbi, I., Kunert-Keil, C., Schroeder, E., Kroemer, H., Siegmund, W., Walker, L., & Pahnke, J. (2004) · Current Alzheimer Research · doi:10.2174/1567205043332225 · Cited by 161
“Cerebral β-amyloid angiopathy (CAA) is one of the characteristic pathological features of AD, although the degree of CAA varies among cases [2,3].”
BackgroundPathogenesis of cerebral amyloid angiopathy
Rensink, A. A. M., de Waal, R. M. W., Kremer, B., & Verbeek, M. M. (2003) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.08.001 · Cited by 159
Antolini, L., DiFrancesco, J. C., Zedde, M., Basso, G., Arighi, A., Shima, A., Cagnin, A., Caulo, M., Carare, R. O., Charidimou, A., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012778 · Cited by 168
Amyloid-β immunisation for Alzheimer's disease
Wisniewski, T., & Konietzko, U. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70170-4 · Cited by 155
Challenges of multimorbidity of the aging brain: a critical update
Jellinger, K. A., & Attems, J. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1288-x · Cited by 154
“These studies corroborated with another study comparing a large number of seniors showing similar age and Braak scores but less severe dementia and more frequent histories of stroke in AD cases with additional CVD (Jellinger 2002), but are at variance with others reporting more severe dementia and less severe AD patho…”
ResultSelf-citationMiners, J. S., Helmond, Z. V., Chalmers, K. A., Wilcock, G. K., Love, S., & Kehoe, P. G. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000240463.87886.9a · Cited by 170
Retinal blood flow in mild cognitive impairment and Alzheimer's disease
Feke, G. T., Hyman, B. T., Stern, R. A., & Pasquale, L. R. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.01.004 · Cited by 172
“Cerebral amyloid angiopathy, characterized by amyloid b (Ab) deposition in the walls of arteries and arterioles has been well documented in AD [28–31].”
BackgroundNeurodegeneration in Normal Brain Aging and Disease
Thal, D. R., Del Tredici, K., & Braak, H. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.23.pe26 · Cited by 149
Pathak, N., Vimal, S. K., Tandon, I., Agrawal, L., Cao, H., & Bhattacharyya, S. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00800-w · Cited by 182
Wojtas, A., Kang, S. S., Olley, B. M., Gatherer, M., Shinohara, M., Lozano, P. A., Liu, C., Kurti, A., Baker, K. E., Dickson, D. W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701137114 · Cited by 156
“CAA is observed in the vast majority of AD patients (7-9), with Aβ deposition typically occurring in leptomeningeal vessels and penetrating arterioles (10).”
Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial
AD Collaborative Group (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70293-4 · Cited by 156
Shams, S., Martola, J., Cavallin, L., Granberg, T., Shams, M., Aspelin, P., Wahlund, L., & Wiberg, M. K. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4248 · Cited by 161
“) (%) 11 (26) 36 (18) 14 (28) 33 (17) 13 (26) 34 (18) MMSE (mean) (SD) 25 (4) 25 (5) 25 (4) 25 (5) 25 (4) 25 (5) BMI (mean) (SD) 27 (5) 25 (3) 25 (4) 27 (5) 25 (4) 27 (5) WMH 1 (No.”
Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia
Roher, A. E., Tyas, S. L., Maarouf, C. L., Daugs, I. D., Kokjohn, T. A., Emmerling, M. R., Garami, Z. F., Bëlohlávek, M., Sabbagh, M. N., Sue, L. I., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.08.228 · Cited by 159
“Furthermore, infarcts are present in approximately 40% of subjects with AD and their presence has been shown to significantly increase the likelihood of dementia in subjects harboring both infarcts and AD histopathology [15–18].”
BackgroundPrevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease
Jellinger, K. A., & Attems, J. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.018 · Cited by 148
“In cohort II, the prevalence of CAA in the frontal cortex of brains with high Braak scores (70%) was lower than in previous series showing 78% to 98% CAA [3,18,23], while over 30% of normal elderly people have CAA [3,30].”
BackgroundResultSelf-citationOptical coherence tomography angiography in preclinical Alzheimer’s disease
van de Kreeke, J. A., Nguyen, H., Konijnenberg, E., Tomassen, J., den Braber, A., ten Kate, M., Yaqub, M. M., van Berckel, B. N. M., Lammertsma, A. A., Boomsma, D. I., et al. (2019) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2019-314127 · Cited by 151
Attems, J., Lintner, F., & Jellinger, K. A. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0822-6 · Cited by 161
“CAA is defined as deposition of a congophilic material in meningeal and cerebral arteries, arterioles, capillaries and veins, representing deposition of Aβ in the vessel walls [ 17 , 29, 46].”
BackgroundSelf-citationJellinger, K. A. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.09.002 · Cited by 179
“Microvascular changes in the aged brain and in AD include mpaired cerebral perfusion, in particular, decrease of regional lood flow, a reduction of glucose transport and utilization, a oss of vascular innervation with special impact on the cholinrgic and other neurotransmitter deficits in AD, impairment of eurogenic c…”
BackgroundSelf-citationThal, D. R., Capetillo-Zarate, E., Larionov, S., Staufenbiel, M., Zurbruegg, S., & Beckmann, N. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.017 · Cited by 138
Roher, A. E., Garami, Z. F., Tyas, S. L., Maarouf, C. L., Kokjohn, T. A., Bëlohlávek, M., Vedders, L. J., Connor, D. J., Sabbagh, M. N., Beach, T. G., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.09.002 · Cited by 153
“These alterations affect the blood–brain barrie, vascular contractility, and vascular integrity, thereby resulting in stenosis as well as vascular fragility promoting cerebral hemorrhages and neuronal injury [11,18].”
BackgroundPericapillary Haem-Rich Deposits: Evidence for Microhaemorrhages in Aging Human Cerebral Cortex
Cullen, K. M., Kócsi, Z., & Stone, J. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600155 · Cited by 137
“Angiopathy is common in AD patients (Jellinger, 2002; Kudo et al, 2000; Shi et al, 2000), with some estimates that a third of such patients have significant cerebrovascular disease (Kalaria, 2002), or that as many as 98% have amyloid angiopathy (Jellinger, 2002).”
BackgroundŠalković‐Petrišić, M., Barilar, J. O., Brückner, M. K., Hoyer, S., Arendt, T., & Riederer, P. F. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0651-4 · Cited by 155
“Amyloid b (Ab) peptide is considered to be a core neuropathological structure of sporadic Alzheimer’s disease (sAD), exhibiting extracellular deposition in the neuropil (forming senile plaques) and the cerebral vasculature (forming cerebral amyloid angiopathy) ( Jellinger 2002 ).”
BackgroundResultShams, S., Martola, J., Granberg, T., Li, X., Shams, M., Fereshtehnejad, S. M., Cavallin, L., Aspelin, P., Kristoffersen-Wiberg, M., & Wahlund, L. O. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4176 · Cited by 132
“3) Vascular dementia (n 54) 67 (4) 50 (3) 0.”
BackgroundChen, K., Maley, J., & Yu, P. H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04181.x · Cited by 131
“A large body of literature suggests that vascular disorders are involved in the pathogenesis of vascular dementia and Alzheimer’s disease (see reviews by Jellinger 2002; Kalaria and Ballard.”
BackgroundPathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives
Fisher, R. A., Miners, J. S., & Love, S. (2022) · Brain Pathology · doi:10.1111/bpa.13061 · Cited by 138
Clifford, P. M., Zarrabi, S., Siu, G., Kinsler, K., Kosciuk, M. C., Venkataraman, V., D’Andrea, M. R., Dinsmore, S. T., & Nagele, R. G. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.070 · Cited by 152
Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3
Koh, S., Noh, M., & Kim, S. H. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.064 · Cited by 137
Metadata
- Authors
- Jellinger, K. A.
- Affiliations
- Ludwig Boltzmann für Klinische Neurobiologie (AT)
- Corresponding author
- Jellinger, K. A.
- ORCID
- Jellinger, K. A.
- Venue
- Journal of Neural Transmission
- Published
- 2002-05-01
- Volume
- 109
- Issue
- 5-6
- Pages
- 813-836
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2084675121
- Cited by
- 680
- References
- 114
- Citations by year
- 2026: 7 · 2025: 25 · 2024: 32 · 2023: 19 · 2022: 38 · 2021: 32 · 2020: 22 · 2019: 26 · 2018: 23 · 2017: 22 · 2016: 30 · 2015: 44 · 2014: 38 · 2013: 27 · 2012: 39
- FWCI
- 14.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, cerebrovascular pathology, cerebral amyloid angiopathy, cerebral hemorrhage, microinfarcts, lacunes, white matter lesions, mixed dementia, vascular dementia, cognitive decline, dementia progression, blood-brain barrier dysfunction
- MeSH terms
- Alzheimer Disease, Blood Vessels, Cerebrovascular Circulation, Cerebrovascular Disorders, Diagnosis, Differential, Humans, Microcirculation, Risk Factors, Dementia, Vascular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.